Oesophageal Cancer Trial, Recruiting NCT06387004 Sponsor: Hopital Forcilles Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT06387004
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been admitted to Hôpital Forcilles to receive radiotherapy for head and neck cancer
  • A trained ultrasound operator must be available at the time of the appointment
  • People who are at least 18 years old at the time of joining the trial
  • People who are members of, or covered by, a French social security scheme
  • People who have given their full, free, and informed agreement to take part

Who may not be able to join:

  • People who have a neurological disorder (a condition affecting the brain or nervous system)
  • People who already had the condition being studied (DR) before starting radiotherapy (confirm with trial site for full details)
  • People who do not wish to take part in the study
  • People who are currently under a legal protection measure known as a "safeguard of justice" in France
  • People who are under guardianship (where another person or authority legally manages their affairs)
  • People whose medical care has been assessed as limited in scope (confirm with trial site for full details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: DIAZ LOPEZ Carlos, PhD st, Hopital Forcilles

Phone: +33160646093

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hopital Forcilles
Registry
ClinicalTrials.gov
Start date
18 January 2024
Est. completion
18 February 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The primary endpoint is the predictive ability of morphology and/or movement of the tongue, hyoid bone and suprahyoid muscles measured by ultrasound on the occurrence of TDs during radiotherapy.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov